Menard Financial Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,392
Closed -$265K 73
2023
Q3
$265K Buy
+8,392
New +$265K 0.38% 59